摘要
膀胱尿路上皮癌是我国最常见的泌尿系统恶性肿瘤。我们就尿液中膀胱癌肿瘤标记物的研究进展进行综述。
出处
《现代医药卫生》
2010年第3期400-402,共3页
Journal of Modern Medicine & Health
参考文献23
-
1Miyanaga N ,Akaza H ,Ishikawas V,et al.Clinical evaluafon of nuclear matrix protein 22(NMP22)in urine as n novel marker for urothelial cancer[J].Eur Urol, 1997,31:163.
-
2Shariat SF ,Casella R ,Wians FH Jr,et al.Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrixprotein22 and cytology[J].Eur Urol,2004,45(3):304.
-
3Akaza H, Miyanaga N,Tsukamoto F,et al.Evaluation of urinary NMP22 as a diagnostic marker for urothelial cancerNMP22 as a urinary marker for surveillance of bladder cancer[J].Gan To Kagal Ryoho, 1997,24(7) : 829.
-
4Lahme S.Comparison of cytology and nuclear matrix protein 22 (NMP22)for the detection and follow-up of bladder-cancer[J].Adv Exp Med Biol,2003,539(A): 111.
-
5Soloway MS,Briggman V,Curpinito GA,et al.Use of a new tumor marker,urinary NMP22 ,in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment[J].J Urol, 1996,156:363.
-
6Friedrich MG, Toma MI, Hellstern A, et al.Comparison of muhitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer[J].BJU Int,2003, 92:911.
-
7Pode D, Shapiro A, Wald M, et al.Noninvasive detection of bladder cancer with the BTA stat test[J].J urol, 1999,161(2) :442.
-
8Bas WG,van Rhijin,Henk G van der Poel,et al.Urine markers for bladder cancer surveillance :A systematic review[J].Eur Urol, 2005, 47 : 736.
-
9Toma MI, Barak V, Hautmann SH, et al.Comparison of the Immunocyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer[J].Word J Urol, 2004,22:145.
-
10Wright WE ,Piayszed MA,Raingy WE,et al.Telomerase activity in human gerrnline and embryonic tissues and eells[J].Dev Genet, 1996, 181 : 173.
同被引文献18
-
1邱国光,雷德利.膀胱移行细胞癌微血管密度与其复发的关系[J].实用医技杂志,2007,14(14):1836-1838. 被引量：5
-
2Szarvas T, Jager T, Laszlo V, et al. Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer[ J]. Urulogy,2012,80( 3 ) :737.
-
3Sun Y W,Xuan Q, Shu QA, et al. Correlation of tumor relapse and el- evated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma [ J]. Genet Mol Res,2013,12(2) :1045 - 1053.
-
4V an Rhijin BW,van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance : a systematic review[J]Eur Urol,2005,47(6) :736-748.
-
5Jacobs BL,Lee CT,Montie JE.Bladder cancer in 2010: how far have we corn [J]CA' Cancer J Clin,2010,60(4): 244-272.
-
6F riedrich MG,Toma mukitarget fluorescence other noninvasive tests Int,2003,gz911. MI,Hellstern A, et aiComparison of in situ hybridization in urine with for detecting bladder cancer I]]BJU.
-
7Bas WG,van Rhijin,Henk G van der Poel,et al.Urine markers for bladder cancer surveillance:A systematic review [J].Eur Urol,2005,47:736.
-
8陈玲,李旭.膀胱癌诊断标志物研究进展[J].中国肿瘤临床,2008,35(8):470-473. 被引量：4
-
9程亮,徐嘉雯,滕晓东.尿路上皮平坦型病变临床病理学进展[J].中华病理学杂志,2010,39(9):577-581. 被引量：2
-
10杨俊伟.透明质酸、透明质酸酶与泌尿系恶性肿瘤的研究进展[J].现代诊断与治疗,2011,22(1):25-28. 被引量：4
-
1虞颂庭,张景全.对免疫组织化学及流式细胞术测定膀胱肿瘤标记物之评价[J].中华泌尿外科杂志,1989,10(4):213-216.
-
2毕长富,张克荣,董浩,王占海,夏增学.尿脱落细胞CK20检测对膀胱癌诊断的意义[J].河北医药,2010,32(12):1537-1538. 被引量：1
-
3都卫国,靳风烁.膀胱肿瘤的新标记物[J].国外医学（泌尿系统分册）,1999,19(4):154-155. 被引量：2
-
4熊林,谭万龙.尿液中膀胱肿瘤标记物的研究进展[J].国外医学（泌尿系统分册）,2005,25(6):792-796.
-
5张日强,左杰,孙光.膀胱癌预后因子的研究现状及进展[J].国外医学（泌尿系统分册）,2002,22(1):39-43. 被引量：2
-
6钟志惟,殷香保.胰腺癌的分子靶向治疗研究进展[J].中国普通外科杂志,2016,25(9):1351-1356. 被引量：12
-
7秦环龙,吴肇汉.胰腺癌的研究现状及进展[J].临床外科杂志,1999,7(2):110-111. 被引量：3
-
8何三光,宋茂民.胰腺癌的研究现状及进展[J].中华普通外科杂志,1997,12(4):195-197. 被引量：7
-
9章小龙(综述),郑军华(审校).前列腺穿刺活检研究现状及进展[J].国际泌尿系统杂志,2011,31(5):659-662. 被引量：2
-
10洪锐,鞠振宇,黄志刚.头颈部鳞状细胞癌肿瘤干细胞研究进展[J].中国耳鼻咽喉头颈外科,2009,16(1):21-23. 被引量：2
